IP Library › Granted Patent US 10,265,396
Granted Patent B2
US 10,265,396 · App. 15/708,089 · Granted Apr 23, 2019

Magnetic extracellular matrix

Inventor: Glauco R. Souza (Houston, TX)
Assignee: Greiner Bio-One North America, Inc.
A61K41/0052A61L27/18A61L27/38A61L27/50A61N2/00C12N5/0062C12N5/0068G01N33/54346G01N33/587A61L2400/12A61L2430/20A61L2430/30B03C1/01B03C1/034B03C1/30B03C2201/26C12N2529/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,265,396
App. No.
15/708,089
Granted
Apr 23, 2019
Kind
B2
Abstract

Methods of making and using a magnetic ECM are disclosed. The ECM comprises positively and negatively charged nanoparticles, wherein one of said nanoparticles contains a magnetically responsive element. When the magnetic ECM is seeded with cells, the cells will be magnetized and can be levitated for 3-D cell culture.

Claims (25)

1. A magnetic extracellular matrix (ECM) made by:

a) placing magnetic nanoparticles inside a cell;

b) levitating said cell in a magnetic field and growing said levitated cell in said magnetic field into a 3D culture of cells having an ECM until said magnetic nanoparticles are lost from said cells and retained by the ECM; and

c) decellularizing said 3D culture of cells using a magnet to levitate and hold said ECM while washing away cell debris to produce a magnetic ECM.

2. The magnetic ECM of claim 1 , wherein said magnetic nanoparticles further comprise:

i) a negatively charged nanoparticle;

ii) a positively charged nanoparticle; and

iii) a support molecule;

wherein one of said negatively charged nanoparticle or positively charged nanoparticle contains a magnetically responsive element, and wherein said support molecule holds said negatively charged nanoparticle and said positively charged nanoparticle in an intimate mat-like admixture.

3. The magnetic ECM of claim 1 , wherein decellularizing step consists essentially of one or more of freeze-thaw, detergent, or osmotic pressure treatments applied to said 3D culture of cells.

4. The magnetic ECM of claim 2 , wherein decellularizing step consists essentially of one or more of freeze-thaw, detergent, or osmotic pressure treatments applied to said 3D culture of cells.

5. A magnetic extracellular matrix (ECM) made by:

a) placing magnetic nanoparticles inside a cell;

b) levitating said cell in a magnetic field and growing said levitated cell in said magnetic field into a 3D culture of cells having an ECM until said magnetic nanoparticles are lost from said cells and retained by the ECM; and

c) decellularizing said 3D culture of cells using a magnet to levitate and hold said ECM while washing away cell debris to produce a magnetic ECM, wherein said decellularizing consists essentially of one or more of freeze-thaw, detergent, or osmotic pressure treatments applied to said 3D culture of cells.

6. A method of preparing tissue for implantation in a patient, said method comprising:

a) seeding the magnetic ECM of claim 1 with allogeneic stem or progenitor cells from a patient;

b) growing said seeded ECM in a magnetic field; and

c) transplanting the seeded ECM from step b) into said patient.

7. The method according to claim 6 , wherein in step a) the magnetic ECM is further seeded with fibroblast cells, epithelial cells, osteoblast cells, or autologous fibroblast cells and epithelial cells.

8. A method of preparing a seeded magnetic ECM, said method comprising:

a) seeding the magnetic ECM of claim 1 with allogeneic stem or progenitor cells from a patient;

b) growing said seeded ECM in a magnetic field.

9. The method according to claim 8 , wherein in step a) the magnetic ECM is further seeded with fibroblast cells, epithelial cells, osteoblast cells or autologous fibroblast cells and epithelial cells.

10. A seeded magnetic ECM made by the method of claim 8 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2018
From: NANO3D BIOSCIENCES, INC.
To: GREINER BIO-ONE NORTH AMERICA, INC.
Reel/Frame 045636/0935 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: SOUZA, GLAUCO R
To: NANO3D BIOSCIENCES, INC.
Reel/Frame 045447/0497 →
Continuity (3)
Division 14404469
Provisional Application 61659970 · Jun 14, 2012
Related Publication 20180000936A1 · Jan 4, 2018